Several genome sequencing programs were launched in Brazil by the end of the nineties and the early 2000 The most important initiatives were supported by the ONSA program (http://watson.fapesp.br/onsa/Genoma3.htm and aimed at gaining domain in genomic technology and bringing molecular biology to the state of art. Two ma sets of data were collected in the 1996-2007 period to evaluate the results of these genome programs: the scientifi production (Scopus and Web of Science databases) and the register of patents (US Patent and Trademark Office), bo related to the progress of molecular biology along this period. In regard to the former, Brazil took a great leap in com parison to 17 other developed and developing countries, being only surpassed by China. As to the register of paten in the area of molecular biology, Brazil's performance lags far behind most of the countries focused in the prese study, confirming the Brazilian long-standing tendency of poor achievements in technological innovations when com pared with scientific production. Possible solutions to surpass this inequality are discussed.
INTRODUCTION
Molecular biology of the gene is an area of contemporary science that permeates several other areas of life sciences. Its concepts and methods have been, for historical reasons, slowly absorbed by the Brazilian Scientific community. For example, in the period of [1965] [1966] [1967] [1968] [1969] [1970] [1971] [1972] [1973] [1974] [1975] the ISI-Thomson Reuters database registered 24 articles published in Brazil in this area, involving approximately ten groups (search for key words expression described below). The authors belonged mainly to the areas of cytology and biochemistry, and the tendency was for a more descriptive study. In the same period, the United them came from laboratories with competent in genetics, microbiology, virology and enzym which were the truly propelling areas of studies lecular biology of the gene (Judson 1979) . The research groups in Brazil with proficiency in thes was certainly a decisive factor for the slow prog molecular biology in the following decades.
Taking these circumstances into consideratio work aims at describing the evolution of scientifi nological production in molecular biology in Bra comparing it to international results, focusing t riod of 1996-2007. The interpretation of the
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ROGÉRIO MENEGHINI and ESTÊVÃO C. GAMBA state of São Paulo, in view that it was the first one to launch these programs through the ONSA-FAPESP initiative (http://watson.fapesp.br/onsa/Genoma3.htm).
In defense of the implementation of the ONSA genomics programs, there was the proposal of rescuing molecular biology (Perez 2002) , maybe more important than genome sequencings themselves. The success of the latter is evident through the publications that they originated. What is less clear is how much such effort meant in terms of a molecular biology advance in Brazil. The recovery of information related to the national scientific production shows that the molecular biology area has achieved a very meaningful growth in Brazil. The fact that countries that had not launched genomics programs did not reach such leaps in molecular biology publications reinforces the assumption that Brazilian genomic programs (Simpson et al. 2000 , Silva et al. 2002 , Brazilian Genome Project Consortium et al. 2003 were fundamental for this progress. However, no technological spin off developments occurred paralleling the scientific progress and, therefore, the great impulse in molecular biology had no impact in terms of technological innovations.
METHODOLOGY
In order to retrieve scientific publications related to the molecular biology area, the SCOPUS database has been used. It was selected for its large coverage of high-impact journals in life sciences. The use of ISIThomson Reuters database was impaired due to the limited results displayed on-line. For example, it does not supply figures that outnumber 100,000 articles (case of the USA and China annual production). However, in one specific case, the SCOPUS and ISI-Thomson Reuters databases results were compared. In order to recover such results, 1996 was adopted as the initial year, for that is the beginning of the Scopus database operational year and because the Brazilian genome programs were launched in the end of this decade. Data compilation occurred in August, 2008.
The expression "RNA OR DNA OR (MOLECUnumber of alternative expressions that have been tested. The results were distributed according to their authors' origin, which was sub-divided into four country groups: Latin-American countries (Argentina, Brazil, Chile and Mexico), developed countries (Germany, United States, United Kingdom, Japan, France and Canada); Asian and African emerging countries (South Africa, China, South Korea and India); and East European countries (Poland, Hungary and the Czech Republic). Finally, the results related to the scientific production in molecular biology in each of these countries were compared to the total scientific production in order to find clues for the progress of molecular biology research in each country. In order to assess the scientific production impact on technological innovation, the registration of patents at the American United States Patent and Trademark Office (USPTO) was used. The covered period was also from 1996 to 2007.
TOTAL SCIENTIFIC PRODUCTION GROWTH AND MOLECULAR BIOLOGY GROWTH IN BRAZIL, IN CONNECTION TO THE INTERNATIONAL SCIENTIFIC PRODUCTION (1996-2007)

BRAZIL IN THE CONTEXT OF LATIN-AMERICAN COUNTRIES
Brazil occupies the leading position in the Latin-American context, where the scientific production growth rate in the period from 1996 to 2007 is considered. According to Table I , the Brazilian scientific production in this period increased 236%, followed by the production of Chile, Mexico and Argentina, which showed increases of 170%, 103% and 75%, respectively. When the scientific production growth rate in molecular biology is analyzed, Brazil also holds the first place in the rank, with an even more dramatic increase of 434% in the 1996-2007 period, followed by Chile, Argentina and Mexico, with increases of 228%, 202% and 160%, respectively (Table II) . 236%, followed by Canada with 54%, United Kingdom with 42%, Germany with 38%, France with 35%, Japan with 16% and the United States with 12% (Table III) . In molecular biology, the Brazilian growth of 434% (Table II) Brazil holds the first place in previous ranks of scientific production, but here it falls to third place. At any rate, Chinese, South Korean and Brazilian predominance in science growth all over the world is evident.
If we compare the Brazilian scientific production in molecular biology to the production of developing countries, we may observe that Brazil holds the second place in the rank with a total of 434%, presenting lower results than China, which has reached an increase of 1243% (Table VI) . South Korea is behind Brazil in this area, with 354%, followed by India with 324% and South Africa with 175%.
BRAZIL AND EAST EUROPEAN COUNTRIES
When compared to East European countries, the Brazilian scientific production growth reached 236%, more than the double increase presented by the Czech Republic, with 93%. After it comes Poland with 74% and Hungary with 55% (Table VII) .
In molecular biology, the difference between Brazil and East European countries decreased, but its production growth remains more expressive than the growth presented by Poland, the Czech Republic and Hungary (Table VIII) .
TOTAL AND MOLECULAR BIOLOGY SCIENTIFIC PRODUCTION GROWTHS IN THE STATE OF SÃO PAULO (SCOPUS AND ISI DATABASES)
São Paulo was the pioneering state in genome projects through the ONSA program of FAPESP. A network was organized for this purpose, which encompassed over one hundred scientists from more than forty institutions of the São Paulo State (Simpson et al. 2000; Silva et al. 2002 , Brazilian Genome Project Consortium et al. 2003 . With the aim of focusing the state of São Paulo production, it was chosen to compare publication data from Scopus and ISI-Thomson Reuters databases in this case. Here, besides the expression "RNA OR DNA OR (MOLECULAR BIOLOGY) OR PCR", the origin (SÃO PAULO or SP and BRASIL or BRAZIL) was also considered in the searches.
countries was due to the fact that the standard da available at the Internet does not allow for defini figures that outnumber 100,000 (e.g., the USA and annual production).
The scientific production evolution in th of São Paulo recovered from the SCOPUS da showed an increase of 257% in the 1996-2007 (Table IX) . In the ISI database, the increase 218% (Table X) . The increase of 257% was higher than the Brazilian increase (236%) in th period (SCOPUS database, Table I ).
In molecular biology, the scientific produc the state of São Paulo had expressive increa 515% on the SCOPUS database (Table XI) 468% on the ISI database (Table XII) . Therefo SCOPUS database reveals that, in this area, th Paulo scientific production increase was 19% than the Brazilian one (Table II) .
Table XIII provides a summary chart of th scientific production and in molecular biology paring Brazil, the state of São Paulo and 16 s countries. China, as we have already seen, has impressive increase of 1,243% in molecular biol the 1996-2007 period. In 1995, China defined th Technology area as its priority number 1 in the N Plan for High Technology, among the 7 areas th been selected as priorities (Zhangliang and Li-Jia Resources and efforts were higher than the one any other emerging country, and this fact may e the great progress they reached in this area.
The Brazilian growth in molecular biology impressive (434%), reaching the second place the countries in the present study. The state Paulo was highlighted in Table XIII due to its p ing genome sequencing programs that have ce influenced the advance of molecular biology, higher than the Brazilian average (515%). It is d to find another explanation for the advances of m lar biology in Brazil and, more specifically, in th of São Paulo.
It is interesting to mention that South Korea "main" -2011/5/13 -17:01 -page 750 -#6
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ROGÉRIO MENEGHINI and ESTÊVÃO C. GAMBA impulse in technological innovation, holding the fourth place in the world in deposits of patents in the US Patent Office, only behind the USA, Japan and Germany. However, as opposed to China and Brazil, there was not any
It should be observed that for all countries the growth of molecular biology production has been higher than their total production, except in the United Kingdom and France. The average production of mo- 
PATENTS GROWTH ANALYSIS
It would be expected that the outstanding growth of Brazilian scientific production in molecular biology from 1996 to 2007 had been followed by an expressive and Chile with 333% (Table XV) . However, despite this increase, the number of patents (Table XV) is still of little significance, 279, less than half the Mexican amount, which is 776.
PATENTS REGISTRATION: COMPARISON BETWEEN BRAZIL AND DEVELOPED COUNTRIES
Taking into account the period of 1996-2007 Brazil stands very weakly when compared to developed countries, as far as the number of patents is concerned. Its growth of 365%, followed by the developed countries that presented a growth rate within the range of 295%, is very low if the aspiration is to reverse the great difference that separates Brazil from these countries, concerning the number of patents that were recorded at USPTO (Table XVI) . Brazil's number of patents shows a more expressive growth in molecular biology when compared to developed countries (Table XVII) . However, the same arguments prevail: the increase rate of patent records should have been much higher in order to diminish the great distance that separates Brazil from the developed countries.
PATENT REGISTRATION: BRAZIL IN THE SETTING OF The Chinese growth was of 5,582%, followed by India with a growth of 3,760%, South Korea with 1,237%, Brazil with 365% and South Africa with 161% (Table  XVIII) .
When the molecular biology patent registration is compared in the same setting, Brazil appears in the third place, with a growth of 3,700%, higher than South Korea and South Africa (Table XIX) . China and India have presented an overwhelming growth in the number of patent records in molecular biology of 5,275% and 4,540%, respectively.
PATENT REGISTRATION: BRAZIL AND EAST EUROPEAN COUNTRIES
The growth of patent registrations in the Czech Republic in all areas is 2,829%, the highest among East European countries (Table XX) . It is followed by Hungary with 389%, Brazil 365% and Poland 349%. However, Table XX also shows that the number of patent registered is low in East European countries, even lower than in Brazil.
Brazil shows a higher position than East European countries concerning the registration of patent in mo-
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ROGÉRIO MENEGHINI and ESTÊVÃO C. GAMBA As opposed to what happens with the scientific production measured by publications, in which São Paulo State national rate: 34% (Table XXII) . Such unfavorable performance is surprising for a state with the most dynamic industrial sector in Brazil. Such disequilibrium is even more surprising when the molecular biology area is focused. Whereas the sci- Mexico achieved a position closer to developed countries in the patents/scientific production correlation. The fact of being geographically close to the United States and also the presence of American industries producing innovations in Mexico certainly have weighted significantly in this context.
Positions are not meaningfully changed in the molecular biology area as shown in Table XXV . Japan was in the first position concerning patents registration normalized by scientific articles in overall fields of science, but it currently reaches the third position in the molecular biology area, being replaced by USA in the first position. India, which occupies the fourth position concerning all fields of sciences, falls down to the ninth position in molecular biology. Korea, with its recognized effort for technological innovation, changes from position 3 to 7 in Tables XXV. It is amazing that São Paulo State is so badly positioned in the area of molecular biology. In fact, some companies emerged in this state as a result of its own genome program with the perspective of innovation, mainly in the agricultural area. However, up to the moment, this has not been translated into a growth of patent registrations at USPTO.
FINAL CONSIDERATIONS
The imbalance between scientific production and technological innovation in Brazil has already been surveyed and discussed by other authors (see, for example, Zanotto 2002). One of the defended positions is that universities should have a more important role in innovation, occupying the room that has been relatively relegated to a second plan until now by the private sector (Galem- 760 ROGÉRIO MENEGHINI and ESTÊVÃO C. GAMBA lowing this point of view, it should be the private sector role to achieve advances in technological innovations. This is undoubtedly the prevailing model in developed countries.
The effort to have expression in specific areas generates positive results, as shown in the case of genomic programs. A wel-organized and well-conducted network, with realistic resources, allowed Brazil and the state of São Paulo to achieve a dramatic expansion in scientific publications, only subdued by China.
Such fact surely constitutes a necessary leap which, however, is not sufficient for a significant rise of the technological innovation process in the area of molecular biology. 
